Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

61 results about "Variant form" patented technology

A variant form is a different glyph for a character, encoded in Unicode through the mechanism of variation sequences: sequences in Unicode that consist of a base character followed by a variation selector character. A variant form usually has a very similar appearance and meaning as its base form.

Discriminating program code updates after merging for live review

A method for dynamically discriminating a program code patch update after merging a patch file into unmodified source code for dynamic review. The method includes providing a graphical user interface (GUI) to enable a user to merge a source code patch file into an existing, pre-modified version of source code to generate a variant form of the existing, pre-modified source code and binary artifacts, via the GUI, presenting a display image highlighting differences between existing, pre-modified source code and the variant form after merging the source code patch file into the existing, pre-modified source code, via the GUI, presenting the user with an option of debugging the existing, pre-modified version of the source code, the GUI presenting linked views highlighting the existing, pre-modified version of the source code with the variant form of the source code, in parallel, debugging the variant form of the source code, the GUI presenting linked views highlighting the existing, pre-modified version with the variant form of the source code, in parallel and debugging both the existing, pre-modified version of the source code and the variant form of the source code, in parallel, while stepping through the existing, pre-modified and variant forms of the source code synchronously, while the GUI presents the linked views.
Owner:IBM CORP

Method for immobilizing human source arginase-1 through surface display

The invention discloses a method for immobilizing human source arginase-1 through surface display. The method comprises the steps of adding signal peptide and charged polypeptide to the amino terminal of a protein cleavage variant (InaK-N) formed on an ice core, fusing human source arginase-1 into the carboxyl terminal, and designing an HA label at the carboxyl terminal; constructing various recombinant plasmids to convert competent escherichia coli cells, so that different genetic engineering strains are obtained; conducting shake-flask culture on the strains; detecting the display efficiency and enzyme activity of human source arginase-1; selecting the strain with the highest enzyme activity for mass culture, conducting efficient L-arginine conversion, and synthesizing L-ornithine. Human source arginase-1 fused in the protein cleavage variant formed on the ice core is effectively displayed on the surface of an escherichia coli cell, so that human source arginase-1 is immobilized. Compared with an original ice core protein display system, the method has the advantage that the display efficiency and enzyme activity of human source arginase-1 are improved remarkably. Compared with a chitin immobilizing method, the method has the advantages that cost is reduced, process is shortened, and purification steps are simplified.
Owner:HUBEI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products